Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308907388> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4308907388 endingPage "S40" @default.
- W4308907388 startingPage "S40" @default.
- W4308907388 abstract "<h3>Introduction</h3> Frequent use of short-acting beta<sub>2</sub>-agonist (SABA) indicates poor asthma control. Participants in CONNECT1 (NCT03890666) used the Reliever Digital System (RDS), which consists of an albuterol Digihaler that transmits data wirelessly to a mobile application and synchronizes with a web-based Dashboard. This exploratory analysis evaluated SABA use among participants with uncontrolled asthma using the RDS. <h3>Methods</h3> In this 12-week study, 333 eligible participants (≥13 years old with suboptimal asthma control [Asthma Control Test (ACT) score <19]) were randomized to the RDS (N=167) or SoC (N=166). Exploratory outcomes included mean weekly SABA usage and mean weekly number of SABA-free days during the 12-week study period, as well as the number of participant-healthcare professional interactions (office visits/phone calls) that were due to increased SABA use, as identified from the Dashboard in the RDS group. <h3>Results</h3> In participants using the RDS (n=135), the weekly average daily SABA inhalations decreased (from 9.1 at Week 1 to 6.3 at Week 12) and the weekly average SABA-free days increased (from 3.4 at Week 1 to 4.6 at Week 12) over the 12-week study period (Figure). Furthermore, out of the 85 interactions in the RDS group, 32 (37.6%) were due to increased SABA use. <h3>Conclusion</h3> SABA use decreased over 12 weeks among participants using the RDS. The SABA use data recorded by the RDS may provide clinically meaningful information to facilitate physician-patient discussions and guide interventions to improve asthma control and reduce reliever need." @default.
- W4308907388 created "2022-11-19" @default.
- W4308907388 creator A5014094986 @default.
- W4308907388 creator A5014925607 @default.
- W4308907388 creator A5042006416 @default.
- W4308907388 creator A5044265604 @default.
- W4308907388 creator A5045088082 @default.
- W4308907388 creator A5054364760 @default.
- W4308907388 creator A5054468503 @default.
- W4308907388 creator A5063255886 @default.
- W4308907388 date "2022-11-01" @default.
- W4308907388 modified "2023-09-28" @default.
- W4308907388 title "SHORT-ACTING BETA2-AGONIST USE REDUCTION AMONG PATIENTS WITH UNCONTROLLED ASTHMA USING A RELIEVER DIGITAL SYSTEM" @default.
- W4308907388 doi "https://doi.org/10.1016/j.anai.2022.08.618" @default.
- W4308907388 hasPublicationYear "2022" @default.
- W4308907388 type Work @default.
- W4308907388 citedByCount "0" @default.
- W4308907388 crossrefType "journal-article" @default.
- W4308907388 hasAuthorship W4308907388A5014094986 @default.
- W4308907388 hasAuthorship W4308907388A5014925607 @default.
- W4308907388 hasAuthorship W4308907388A5042006416 @default.
- W4308907388 hasAuthorship W4308907388A5044265604 @default.
- W4308907388 hasAuthorship W4308907388A5045088082 @default.
- W4308907388 hasAuthorship W4308907388A5054364760 @default.
- W4308907388 hasAuthorship W4308907388A5054468503 @default.
- W4308907388 hasAuthorship W4308907388A5063255886 @default.
- W4308907388 hasConcept C126322002 @default.
- W4308907388 hasConcept C1862650 @default.
- W4308907388 hasConcept C187212893 @default.
- W4308907388 hasConcept C2776042228 @default.
- W4308907388 hasConcept C2777394947 @default.
- W4308907388 hasConcept C33499554 @default.
- W4308907388 hasConcept C41008148 @default.
- W4308907388 hasConcept C71924100 @default.
- W4308907388 hasConcept C77088390 @default.
- W4308907388 hasConceptScore W4308907388C126322002 @default.
- W4308907388 hasConceptScore W4308907388C1862650 @default.
- W4308907388 hasConceptScore W4308907388C187212893 @default.
- W4308907388 hasConceptScore W4308907388C2776042228 @default.
- W4308907388 hasConceptScore W4308907388C2777394947 @default.
- W4308907388 hasConceptScore W4308907388C33499554 @default.
- W4308907388 hasConceptScore W4308907388C41008148 @default.
- W4308907388 hasConceptScore W4308907388C71924100 @default.
- W4308907388 hasConceptScore W4308907388C77088390 @default.
- W4308907388 hasIssue "5" @default.
- W4308907388 hasLocation W43089073881 @default.
- W4308907388 hasOpenAccess W4308907388 @default.
- W4308907388 hasPrimaryLocation W43089073881 @default.
- W4308907388 hasRelatedWork W169852945 @default.
- W4308907388 hasRelatedWork W2016837007 @default.
- W4308907388 hasRelatedWork W2025861834 @default.
- W4308907388 hasRelatedWork W2040680927 @default.
- W4308907388 hasRelatedWork W2087666617 @default.
- W4308907388 hasRelatedWork W2374430816 @default.
- W4308907388 hasRelatedWork W2387033042 @default.
- W4308907388 hasRelatedWork W2410569622 @default.
- W4308907388 hasRelatedWork W2416188797 @default.
- W4308907388 hasRelatedWork W4235375593 @default.
- W4308907388 hasVolume "129" @default.
- W4308907388 isParatext "false" @default.
- W4308907388 isRetracted "false" @default.
- W4308907388 workType "article" @default.